Evaluation of C-Reactive Protein Prior to and On-Treatment as a Predictor of Benefit From Atorvastatin: Observations From the Anglo-Scandinavian Cardiac Outcomes Trial

Study Questions:

Among subjects enrolled in the ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial), was C-reactive protein (CRP) associated with increased risk of cardiovascular outcomes?